Nanjing Vazyme Biotech Co Ltd (688105) — Cash Flow Reinvestment Rate
Nanjing Vazyme Biotech Co Ltd (688105) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥15.83 Million (capex CN¥15.83 Million ) from operating cash flow of CN¥75.30 Million. See 688105 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nanjing Vazyme Biotech Co Ltd Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. For the full cash flow conversion analysis, see Nanjing Vazyme Biotech Co Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Nanjing Vazyme Biotech Co Ltd (2019–2025)
Year-by-year capital reinvestment analysis for Nanjing Vazyme Biotech Co Ltd. See financial flexibility index of Nanjing Vazyme Biotech Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.39x | CN¥323.20 Million | CN¥233.16 Million | CN¥47.39 Million | ▼ -75.7% |
| 2023 | 5.71x | CN¥1.13 Billion | CN¥198.40 Million | CN¥232.90 Million | ▲ +119.3% |
| 2022 | 2.61x | CN¥1.92 Billion | CN¥735.17 Million | CN¥962.86 Million | ▼ -4.9% |
| 2021 | 2.74x | CN¥1.69 Billion | CN¥616.80 Million | CN¥261.96 Million | ▲ +102.8% |
| 2020 | 1.35x | CN¥1.09 Billion | CN¥803.55 Million | CN¥152.54 Million | ▼ -36.0% |
| 2019 | 2.11x | CN¥32.08 Million | CN¥15.20 Million | CN¥19.88 Million | — |